Ellipsis Health utilizes a Deep Listening platform and patented voice biomarker technology to analyze speech patterns for real-time mental health assessments. This approach enhances patient-provider interactions, improves care quality, and reduces administrative costs by up to 50%.
Funding
$39.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Healthcare providers often lack efficient and objective tools for mental health screening and assessment, leading to delayed diagnoses and suboptimal care. Traditional methods rely heavily on subjective patient reporting and time-intensive clinical interviews, creating bottlenecks and limiting access to timely interventions.
Solution
Ellipsis Health offers a Deep Listening platform that employs patented voice biomarker technology to analyze speech patterns and provide real-time mental health assessments. By extracting acoustic and semantic features from brief voice samples (60-90 seconds), the platform identifies potential mental health conditions, enhancing patient-provider interactions and improving the quality of care. The technology supports both acoustics and semantics. The platform aims to improve patient and provider experience, drive workflow efficiencies, and reduce the cost of care.
Target Audience
The primary target audience includes healthcare providers, hospitals, and care management organizations seeking to improve mental health screening, assessment, and care delivery.
Features
- Voice biomarker analysis using both acoustic and semantic speech features
- Mental health condition identification from short voice samples
- Integration with existing care management workflows
- Peer-reviewed science and patented technology
- Large database of labeled speech data for algorithm training and validation (2M+ minutes and counting)